Marie De Matharel

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching

R. Anty, L. Mineur, M. Bourlière, 2022, World journal of gastrointestinal oncology.

The severity of symptoms is insufficient to predict major alterations to quality of life of patients with fecal incontinence or chronic constipation

R. Anty, T. Piche, D. Ouizeman, 2020, International Journal of Colorectal Disease.